Concentrix Corp
Financial highlights
| Metric | FY 11/30/25 | FY 11/30/24 | FY 11/30/23 | FY 11/30/22 | FY 11/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.8B | $9.6B | $7.1B | $6.3B | $5.6B |
| Cost of revenue | $6.4B | $6.2B | $4.5B | $4.1B | $3.6B |
| Gross profit | $3.4B | $3.4B | $2.6B | $2.3B | $2.0B |
| Selling, general & administrative | $2.8B | $2.9B | $1.9B | $1.6B | $1.4B |
| Operating income | -$918.2M | $596.4M | $661.3M | $640.2M | $572.4M |
| Interest expense | $290.3M | $321.8M | $201.0M | $70.1M | $23.0M |
| Pretax income | -$1.2B | $299.3M | $408.2M | $605.0M | $555.7M |
| Income tax expense | $96.7M | $48.1M | $94.4M | $169.4M | $150.1M |
| Net income | -$1.3B | $251.2M | $313.8M | $435.0M | $405.6M |
| Balance Sheet | |||||
| Cash and equivalents | $327.3M | $240.6M | $295.3M | $145.4M | $182.0M |
| Current assets | $3.1B | $2.8B | $2.9B | $1.8B | $1.5B |
| Total assets | $10.8B | $12.0B | $12.5B | $6.7B | $5.0B |
| Current liabilities | $2.2B | $2.0B | $2.1B | $1.1B | $968.2M |
| Total liabilities | $8.0B | $8.0B | $8.3B | $4.0B | $2.4B |
| Total debt | $4.7B | $4.8B | $5.0B | $2.2B | $805.0M |
| Stockholders' equity | $2.7B | $4.0B | $4.1B | $2.7B | $2.6B |
| Cash Flow Statement | |||||
| Cash from operations | $807.0M | $667.5M | $678.0M | $600.7M | $514.2M |
| Depreciation and amortization | $226.1M | $246.9M | $173.5M | $146.9M | $140.2M |
| Stock-based compensation | $96.4M | $96.1M | $62.1M | $47.1M | $36.2M |
| Capital expenditure | $234.5M | $238.8M | $180.5M | $140.0M | $149.1M |
| Free cash flow | $572.5M | $428.7M | $497.5M | $460.7M | $365.1M |
| Dividends paid | $89.6M | $83.8M | $63.5M | $53.4M | $13.1M |
| Share repurchases | $168.7M | $136.1M | $64.0M | $120.8M | $25.1M |
| Impairments | $1.5B | $0 | $0 | — | — |
Shares outstanding 61.0M · Free float 82.4%
Annual filing data through FY ended November 30, 2025; float as of July 15, 2026.